Your browser doesn't support javascript.
loading
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
Zhao, Juanjuan; Yuan, Quan; Wang, Haiyan; Liu, Wei; Liao, Xuejiao; Su, Yingying; Wang, Xin; Yuan, Jing; Li, Tingdong; Li, Jinxiu; Qian, Shen; Hong, Congming; Wang, Fuxiang; Liu, Yingxia; Wang, Zhaoqin; He, Qing; Li, Zhiyong; He, Bin; Zhang, Tianying; Fu, Yang; Ge, Shengxiang; Liu, Lei; Zhang, Jun; Xia, Ningshao; Zhang, Zheng.
Afiliação
  • Zhao J; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • Yuan Q; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Wang H; School of Public Health, Xiamen University, Xiamen, China.
  • Liu W; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • Liao X; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Su Y; School of Public Health, Xiamen University, Xiamen, China.
  • Wang X; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • Yuan J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Li T; School of Public Health, Xiamen University, Xiamen, China.
  • Li J; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • Qian S; Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Hong C; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Wang F; School of Public Health, Xiamen University, Xiamen, China.
  • Liu Y; Department of Critical Care Medicine, Shenzhen Third People's Hospital, Shenzhen, China.
  • Wang Z; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • He Q; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Li Z; School of Public Health, Xiamen University, Xiamen, China.
  • He B; Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Zhang T; Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Fu Y; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Ge S; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Liu L; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Zhang J; School of Public Health, Xiamen University, Xiamen, China.
  • Xia N; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Xiamen, China.
  • Zhang Z; School of Public Health, Xiamen University, Xiamen, China.
Clin Infect Dis ; 71(16): 2027-2034, 2020 11 19.
Article em En | MEDLINE | ID: mdl-32221519
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos